← Leaderboards
Petter Bjornstad
University Of Colorado Denver
$9,008,713
Attributed
$14,684,811
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,684,811 · 9
By mechanism
R01$10,546,117 · 5
U01$2,933,933 · 2
K23$962,700 · 1
R21$242,061 · 1
Top collaborators
- Ian H De Boer5 shared
- Kristen J Nadeau4 shared
- Karin E. Bornfeldt2 shared
- Jessica B Kendrick2 shared
- Kristen Lynn Nowak2 shared
- Tomas Vaisar2 shared
- Berenice Yolande Gitomer1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Melanie G Cree$5,579,720
- Kerrie Moreau$13,944,323
- Jessica B Kendrick$6,258,606
- Gary L. Pierce$2,308,898
- Joshua M Thurman$14,218,696
Others in their field
Other Emerging Leaders on “Kidney”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Chani Eduard · Precision Bioservices, Inc.$19,909,203
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Barbara Halina Braffett · George Washington University$18,816,779
- Ionut Bebu · George Washington University$18,816,779
- Noel P Burtt · Broad Institute, Inc.$12,561,765
Research focus
KidneyAdultMetabolicMagnetic Resonance ImagingDiabetic NephropathyGlomerular Filtration RateInsulin ResistanceObesityKidney DiseasesInsulin SensitivityTissuesYouthNon-Insulin-Dependent Diabetes MellitusComplexDiabetes MellitusPrematureIohexolInsulin-Dependent Diabetes MellitusCessation Of LifeStructureNovel TherapeuticsRenal FunctionGlucose ClampRenal Hypoxia
Grant awards (27)
Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank$1,042,430
U01 · FY2025 · DK
KPMP in Type 1 Diabetes: A UW Medicine Collaboration$810,823
U01 · FY2025 · DK · contact PI
Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism$677,909
R01 · FY2025 · DK
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort$606,603
R01 · FY2025 · DK
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)$598,776
R01 · FY2025 · HL
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients$589,086
R01 · FY2025 · DK
Puberty, diabetes, and the kidneys, when eustress becomes distress$509,557
R01 · FY2025 · DK · contact PI
Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank$1,080,680
U01 · FY2024 · DK
Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism$692,934
R01 · FY2024 · DK
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients$665,824
R01 · FY2024 · DK
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)$610,712
R01 · FY2024 · HL
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort$558,239
R01 · FY2024 · DK
Puberty, diabetes, and the kidneys, when eustress becomes distress$515,650
R01 · FY2024 · DK · contact PI
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)$619,880
R01 · FY2023 · HL
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort$591,182
R01 · FY2023 · DK
Puberty, diabetes, and the kidneys, when eustress becomes distress$529,902
R01 · FY2023 · DK · contact PI
Unraveling the Impact of Per- and Polyfluoroalkyl Substances on Early Kidney Injury in Adolescents with Obesity and Diabetes$466,586
R01 · FY2023 · DK · contact PI
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort$639,223
R01 · FY2022 · DK
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)$618,131
R01 · FY2022 · HL
Puberty, diabetes, and the kidneys, when eustress becomes distress$528,793
R01 · FY2022 · DK · contact PI
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study$192,240
K23 · FY2022 · DK · contact PI
Puberty, diabetes, and the kidneys, when eustress becomes distress$527,130
R01 · FY2021 · DK · contact PI
Measuring metabolically active kidney tissue in autosomal dominant polycystic kidney disease$242,061
R21 · FY2021 · DK · contact PI
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study$192,240
K23 · FY2021 · DK · contact PI
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study$192,240
K23 · FY2020 · DK · contact PI
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study$192,240
K23 · FY2019 · DK · contact PI
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study$193,740
K23 · FY2018 · DK · contact PI